← FDA DRUG APPROVALS

FDA ANDA · ANDA075147

ISOSORBIDE MONONITRATE

Sponsor: ANI PHARMS

APPLICATION
ANDA075147
TYPE
ANDA
ORIGINAL APPROVAL
1998-11-27
LATEST ACTION
2000-06-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

ISOSORBIDE MONONITRATEPrescription
ISOSORBIDE MONONITRATE 10MG · TABLET · ORAL
ISOSORBIDE MONONITRATEPrescription
ISOSORBIDE MONONITRATE 20MG · TABLET · ORAL

Approval history

2000-06-07Labeling · Supplement 3AP
2000-03-20Labeling · Supplement 2AP
1999-09-23Manufacturing (CMC) · Supplement 1AP
1998-11-27OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →